BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2696954)

  • 21. Renal osteodystrophy.
    Teitelbaum SL
    Hum Pathol; 1984 Apr; 15(4):306-23. PubMed ID: 6370824
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone histomorphometry in renal osteodystrophy.
    Ott SM
    Semin Nephrol; 2009 Mar; 29(2):122-32. PubMed ID: 19371803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone changes in chronic renal diseases].
    Kontek M; Raszeja-Wanic B
    Pol Arch Med Wewn; 1971 Oct; 47(4):343-50. PubMed ID: 5159660
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease.
    Fogelman I; Carr D
    Clin Radiol; 1980 May; 31(3):321-6. PubMed ID: 7428273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphological analysis of bone dynamics and metabolic bone disease. Renal Osteodystrophy and New KDIGO CKD-MBD classification].
    Tsukamoto Y
    Clin Calcium; 2011 Apr; 21(4):593-7. PubMed ID: 21447928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
    Joffe P; Heaf JG; Jensen C
    Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the pathogenesis and pathophysiology of renal osteodystrophy. II. Bone histology of chronic renal failure patients at the time of starting hemodialysis].
    Sato T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1145-58. PubMed ID: 7815747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone scintigraphy in renal osteodystrophy.
    de Graaf P; Schicht IM; Pauwels EK; te Velde J; de Graeff J
    J Nucl Med; 1978 Dec; 19(12):1289-96. PubMed ID: 104017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.
    Parfitt AM
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):387-403. PubMed ID: 12815335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
    Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone histology and clinical diagnostic criteria in aluminum-induced bone disease].
    Zhu JM
    Zhonghua Nei Ke Za Zhi; 1992 Jul; 31(7):413-6, 414. PubMed ID: 1298595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.
    Bisballe S; Eriksen EF; Melsen F; Mosekilde L; Sørensen OH; Hessov I
    Gut; 1991 Nov; 32(11):1303-7. PubMed ID: 1752460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renal osteopathy and its significance for the orthopedic surgeon].
    Horn V; Spohrová D; Stêpán J; Vokrouhlická O
    Z Orthop Ihre Grenzgeb; 1983; 121(3):283-7. PubMed ID: 6613271
    [No Abstract]   [Full Text] [Related]  

  • 37. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.
    Lafage MH; Combe C; Fournier A; Aparicio M
    Kidney Int; 1992 Nov; 42(5):1217-25. PubMed ID: 1453606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
    Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mast cells and bone tissue changes].
    Rebel A; Riberi P; Bregeon P; Malkani K
    Pathol Biol (Paris); 1974 Mar; 22(3):213-20. PubMed ID: 4603675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.